Brighthouse Financial (BHF) Reports Q3 Earnings: What Key Metrics Have to Say
Werte in diesem Artikel
Brighthouse Financial (BHF) reported $2.17 billion in revenue for the quarter ended September 2025, representing a year-over-year decline of 0.3%. EPS of $4.54 for the same period compares to $3.99 a year ago.The reported revenue represents a surprise of -3.6% over the Zacks Consensus Estimate of $2.25 billion. With the consensus EPS estimate being $5.09, the EPS surprise was -10.81%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how Brighthouse Financial performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Net flows - Variable and Shield Level Annuities: $-2.29 billion versus $-2.11 billion estimated by four analysts on average.Variable and Shield Level Annuities Account Value, end of period: $130.47 billion versus $133.18 billion estimated by four analysts on average.Life Account Value - General Account - Universal and variable universal life account value, end of period: $2.62 billion compared to the $2.61 billion average estimate based on four analysts.Universal Life with Secondary Guarantees Account Value, end of period: $4.55 billion compared to the $4.56 billion average estimate based on four analysts.Revenues- Net investment income: $1.33 billion versus the five-analyst average estimate of $1.42 billion. The reported number represents a year-over-year change of +3.6%.Revenues- Other revenues: $143 million compared to the $151.5 million average estimate based on five analysts. The reported number represents a change of 0% year over year.Revenues- Premiums: $170 million versus the five-analyst average estimate of $194.2 million. The reported number represents a year-over-year change of -5.6%.Revenues- Universal life and investment-type product policy fees: $531 million versus the five-analyst average estimate of $598.94 million. The reported number represents a year-over-year change of -5.2%.Total adjusted revenues- Life: $297 million versus $297.22 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a -2% change.Total adjusted revenues- Annuities: $1.34 billion compared to the $1.38 billion average estimate based on four analysts. The reported number represents a change of +1.7% year over year.Total adjusted revenues- Run-off: $385 million compared to the $387.62 million average estimate based on four analysts. The reported number represents a change of +2.1% year over year.Total adjusted revenues- Corporate & Other: $153 million versus $174.7 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a -16.4% change.View all Key Company Metrics for Brighthouse Financial here>>>Shares of Brighthouse Financial have returned +36% over the past month versus the Zacks S&P 500 composite's -0.2% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.Zacks' Research Chief Picks Stock Most Likely to "At Least Double"Our experts have revealed their Top 5 recommendations with money-doubling potential – and Director of Research Sheraz Mian believes one is superior to the others. Of course, all our picks aren’t winners but this one could far surpass earlier recommendations like Hims & Hers Health, which shot up +209%.See Our Top Stock to Double (Plus 4 Runners Up) >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Brighthouse Financial, Inc. (BHF): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: Brighthouse Financial und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!
Ausgewählte Hebelprodukte auf Brighthouse Financial
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Brighthouse Financial
Der Hebel muss zwischen 2 und 20 liegen
| Name | Hebel | KO | Emittent |
|---|
| Name | Hebel | KO | Emittent |
|---|
Quelle: Zacks
Nachrichten zu Brighthouse Financial Inc Registered Shs When Issued
Analysen zu Brighthouse Financial Inc Registered Shs When Issued
| Datum | Rating | Analyst | |
|---|---|---|---|
| 02.01.2018 | Brighthouse Financial Buy | Deutsche Bank AG |
| Datum | Rating | Analyst | |
|---|---|---|---|
| 02.01.2018 | Brighthouse Financial Buy | Deutsche Bank AG |
| Datum | Rating | Analyst | |
|---|---|---|---|
Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar. Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv | |||
| Datum | Rating | Analyst | |
|---|---|---|---|
Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar. Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv | |||
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Brighthouse Financial Inc Registered Shs When Issued nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen